(Q36776253)

English

Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities

scientific article published on 11 July 2012

Statements

Ponatinib suppresses the development of myeloid and lymphoid malignancies associated with FGFR1 abnormalities (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit